ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Renshen Chishao Decoction Could Ameliorate the Acute Lung Injury but Could Not Reduce the Neutrophil Extracellular Traps Formation

Yao, Miao-En; Huang, Yi; Dong, Qing-Qing; Lu, Yi; Chen, Wei*广州中医药大学
Evidence-based Complementary and Alternative Medicine2022-8-29DOI: 10.1155/2022/7784148
1被引9阅读
引用收藏
分享

摘要

The acute lung injury (ALI) causes severe pulmonary diseases, leading to a high mortality rate. The Renshen and Chishao have protective and anti-inflammatory effects against the ALI. To explore the protective effects of the Renshen Chishao (RC) decoction against the ALI, we established the lipopolysaccharide-indued ALI model and randomly divided the mice into seven groups: control group, ALI group, high-dose RC group, middle-dose RC group, low-dose RC group, middle-dose RC group + CXCR2 antagonist group, and ALI + CXCR2 antagonist group. We estimated the lung injury by the hematoxylin and eosin staining, the neutrophil extracellular traps (NETs) formations by the immunofluorescence colocalization and enzyme-linked immunosorbent assay (ELISA), and the CXCR2/CXCL2 pathway by the flow cytometry, ELISA, and real-time polymerase chain reaction. We conducted the high-throughput sequencing and enrichment analyses to explore the potential mechanisms. The results showed that the RC decoction pathologically ameliorated the lipopolysaccharide-induced lung injury and inflammatory response but failed to reduce the circulating and lung tissue NETs formation and the blood neutrophil percent. The high-dose RC decoction increased the plasma CXCL2 level, but the RC decoction had no effects on the neutrophilic CXCR2 levels. Under the inhibition of the CXCR2, the middle-dose RC decoction still decreased the lung injury score but as yet had unobvious influence on the NETs formation. Other potential mechanisms of the RC decoction against the ALI involved the pathways of ribosome and coronavirus disease 2019 (COVID-19); the target genes of inflammatory factors, such as Ccl17, Cxcl17, Cd163, Cxcr5, and Il31ra, and lncRNAs; and the regulations of the respiratory cilia. In conclusion, the RC decoction pathologically ameliorated the lipopolysaccharide-induced lung inflammatory injury via upregulating the CXCL2/CXCR2 pathway but could not reduce the circulating or lung tissue NETs formation.

学科与关键词

关键词
EXPRESSION
相关
加载中…
  • Modified Xiaoqinglong decoction alleviates lipopolysaccharide-induced acute lung injury in mice by regulating arachidonic acid metabolism and exerting anti-apoptotic and anti-inflammatory effects
    Ruan, Yongdui*; Fan, Yaohua; Xie, Yanfeng; Ma, Chunling; Mo, Bingquan; Lai, Yanni; Li, Geng; Liu, Xiaohong*; Kuang, Weihong*Anatomical Record, 2022, 305(7): 1672-1681.被引 4
  • Inhibition of inflammasome activation via sphingolipid pathway in acute lung injury by Huanglian Jiedu decoction: An integrative pharmacology approach
    Chen, Ying; Peng, Mingming; Li, Wei; Zhao, Mantong; Cao, Xia; Li, Chuanqiu; Zhang, Han; Yang, Mengru; Liang, Lanyuan; Yue, Yiming; Xia, Tianyi; Zhong, Renxing; Wang, Yi; Shu, Zunpeng*PHYTOMEDICINE, 2022, 107: 154469.被引 8
  • Integrated Pharmacology Reveals the Molecular Mechanism of Gegen Qinlian Decoction Against Lipopolysaccharide-induced Acute Lung Injury
    Li, Wei; Ding, Zihe; Chen, Ying; Wang, Yi; Peng, Mingming; Li, Chuanqiu; Zhang, Han; Zhong, Renxing; Xia, Tianyi; Zhong, Luyang; Zhao, Mantong; Yang, Mengru; Yue, Yimin; Liang, Lanyuan; Cao, Xia; Shu, Zunpeng*Frontiers in Pharmacology, 2022, 13: 854544.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-08-29
卷期
第 2022 卷
页码
7784148
DOI
10.1155/2022/7784148
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Shanghai Platform Construction of Integrated Chinese and Western Medicines Response and Intervention on Major Critical Medical Events [ZY2018-2020-FWTX-7004]; Shanghai University of Traditional Chinese Medicine Special Project of Postgraduate Innovation Training [Y2021014]

作者

  • Y

    Yao, Miao-En (第一作者)

    2 · guangzhou univ chinese med · shanghai univ tradit chinese med

  • H

    Huang, Yi

    shanghai univ tradit chinese med

查看全部 5 位作者收起作者
  • D

    Dong, Qing-Qing

    shanghai univ tradit chinese med

  • L

    Lu, Yi

    shanghai univ tradit chinese med

  • C

    Chen, Wei (通讯)

    shanghai univ tradit chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417